Novel algorithm for HF screening receives FDA breakthrough designation

Eko announced that a novel ECG-based algorithm to screen for HF has been granted breakthrough device status from the FDA. “Roughly 7 million Americans have a weak heart pump and don’t know it,” Paul A. Friedman, MD, chair of the department of cardiovascular medicine at Mayo Clinic in Rochester, Minnesota, told Healio. “They either have no symptoms or they may attribute their

Read the full article here

Related Articles